Ramaswamy Chandrashekar

Dr. Ramaswamy Chandrashekar


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Comparative Immunology, Microbiology and Infectious Diseases
Verified
Journal Article
Open access
MBMelissa Beall
Melissa Beall
JBJesse Buch
Jesse Buch
RCRoberta J. Cahill
Roberta J. Cahill
GCGenevieve Clark
Genevieve Clark
JHJancy Hanscom
Jancy Hanscom
RCRamaswamy Chandrashekar
Ramaswamy Chandrashekar
Feline leukemia virus (FeLV) is an oncogenic retrovirus of cats. While higher viral RNA and proviral DNA loads have been correlated with progressive infections and disease, a similar correlation has been suggested for p27 antigen concentrations. This analytical study compared the results of a quantitative ELISA for p27 antigen with quantitative real-time PCR results for FeLV proviral DNA in patient samples. A significant positive correlation between copies of proviral DNA and the concentration of p27 antigen was identified (r = 0.761, P < 0.0001). Samples with high proviral DNA loads, at least 1 × 106 copies/mL of whole blood, typically had p27 antigen concentrations greater than 30 ng/mL in plasma. Samples with proviral DNA loads below this level all had concentrations of p27 antigen in plasma that were less than 10 ng/mL. Given this correlation, it is hypothesized that the concentration of p27 antigen at a given point in time may help to indicate the likelihood of a progressive or regressive infection similar to what has been demonstrated for proviral DNA loads.

1 February 1990 in Journal of Parasitology
Verified
Journal Article
Closed access
GWGary J. Weil
Gary J. Weil
RCRamaswamy Chandrashekar
Ramaswamy Chandrashekar
FLFanya Liftis
Fanya Liftis
CMCatherine S. McVay
Catherine S. McVay
SBStephen C. Bosshardt
Stephen C. Bosshardt
TKThomas R. Klei
Thomas R. Klei
The Mongolian jird is used widely in filariasis research for studies of protective immunity, pathogenesis, and therapy. The purpose of this study was to evaluate parasite antigen detection as a means of noninvasively monitoring Brugia pahangi infection in jirds. A parasite antigen with Mr of 105-110 kDa was identified in sera from i.p.- and s.c.-infected jirds by immunoblot with a monoclonal antibody to phosphorylcholine. The same antibody was used in a direct sandwich enzyme immunoassay to measure antigen in jird sera. Parasite antigen was detectable as early as 2 wk after i.p. or s.c. injection of L3. Antigen titers increased between 2 and 12 wk and stabilized between 12 and 36 wk after infection in s.c.-infected animals. A different pattern was seen in i.p.-infected jirds with antigen titers peaking at 16 wk and falling significantly between 16 and 32 wk after infection. Parasite antigen titers correlated significantly with adult worm infection intensities in jirds with mature i.p. and s.c. infections. Antigenemia was also detectable in sera from jirds after i.p. implantation of adult parasites of either sex. However, antigen was not detected in sera from infant offspring of antigenemic infected mothers. We conclude that parasite antigen detection allows B. pahangi development and survival as well as infection intensity to be monitored in living animals with unprecedented sensitivity and accuracy. This technique should facilitate drug and vaccine studies in this important experimental filariasis model.

1 May 1997 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
RCRamaswamy Chandrashekar
Ramaswamy Chandrashekar
KCK C Curtis
K C Curtis
BRB W Rawot
B W Rawot
GKG S Kobayashi
G S Kobayashi
GWG J Weil
G J Weil
Immunological cross-reactivity among fungi has hampered the development of specific serodiagnostic assays for histoplasmosis. We report the molecular cloning and characterization of a Histoplasma capsulatum cDNA (GH17) that encodes an antigen with immunodiagnostic potential. GH17 is an 810-bp cDNA which encodes a protein of 211 amino acid residues. The GH17 sequence has almost no significant homology with other sequences in GenBank. Southern blot analysis suggests that GH17 is confined to a single location in the genomic DNA of H. capsulatum. Immunoblots indicated that the protein product of GH17 (expressed as a 140-kDa beta-galactosidase fusion protein) was recognized by antibodies in 18 of 18 sera from histoplasmosis patients, but not by antibodies in sera from patients or animals infected with other fungi. GH17 was expressed in a prokaryotic expression vector, pPROEX-1, and recombinant protein was purified by preparative electrophoresis. Antibodies raised to this protein bound to a 60-kDa native antigen in immunoblots of H. capsulatum yeast antigen extract. These results suggest that GH17 encodes an H. capsulatum antigen that may be useful for the diagnosis of histoplasmosis in humans.

1 December 2020 in Veterinary Microbiology
Verified
Journal Article
Closed access
LCL. Cortese
L. Cortese
MBM. Beall
M. Beall
FBF. Buono
F. Buono
JBJ. Buch
J. Buch
LPL. Pacifico
L. Pacifico
DPD. Piantedosi
D. Piantedosi

1 December 2019 in Topics in Companion Animal Medicine
Verified
Journal Article
Open access
BSBrett A. Stillman
Brett A. Stillman
BTBrendon Thatcher
Brendon Thatcher
MBMelissa J. Beall
Melissa J. Beall
MLMichael Lappin
Michael Lappin
TOThomas P. O'COnnor
Thomas P. O'COnnor
RCRamaswamy Chandrashekar
Ramaswamy Chandrashekar
Vaccines against Borrelia burgdorferi are administered frequently to dogs in areas endemic for the infection. These vaccines produce an antibody response to spirochetal proteins that cross-react in many antibody tests, including immunofluorescence assay, Western blot, and whole cell ELISA used to document exposure to B. burgdorferi. The purpose of this study was to determine whether the in-clinic C6 ELISA assay (SNAP® 4Dx® Plus; IDEXX Laboratories, Inc., Westbrook, Maine) and the quantitative format C6 ELISA (Lyme Quant C6® Antibody Test, IDEXX Laboratories, Inc., Westbrook, ME) react to sera from dogs that have been vaccinated with 1 of 4 different commercially available B. burgdorferi vaccines. Four groups of 3 dogs each were each administered one of the 4 vaccines and sera evaluated over time by indirect fluorescent antibody assay, western blot immunoassay, the in-clinic C6 ELISA assay, and the quantitative format C6 ELISA. While all dogs developed B. burgdorferi antibodies detectable by indirect fluorescent antibody assay and western blot immunoassay after vaccination, none of the samples were positive in either of the C6 peptide-based assays. Based on these results, positive anti-C6 antibody results in client-owned dogs are likely to reflect exposure to B. burgdorferi rather than vaccination.

19 October 2023 in Viruses
Verified
Journal Article
Open access
PDF file
SSSeema Singh
Seema Singh
KDKristen Anne Davenport
Kristen Anne Davenport
ESElizabeth Schooley
Elizabeth Schooley
ARAnthony Ruggiero
Anthony Ruggiero
SNSalam Nassar
Salam Nassar
RCRamaswamy Chandrashekar
Ramaswamy Chandrashekar
Feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) are retroviral infections of cats worldwide whose clinical manifestations range from mild to severe disease. In both cases, infected cats can live a long life with proper care and should be managed to prevent infection of other cats. Dirofilaria immitis, the nematode that causes heartworm disease, can infect cats in any region where dogs are infected. Though cats are more resistant to infection, clinical diseases in the form of heartworm-associated respiratory disease can cause death. Screening for these infectious diseases enables veterinarians to manage their cases and prevent the spread to other cats. We describe the diagnostic accuracy of a point-of-care immunoassay for FIV, FeLV, and heartworm, compared to reference methods commonly available through reference laboratories to the practicing veterinarian. For FIV, we report 100% sensitivity (95% confidence limits (CL): 96.2–100%) and 97.8% specificity (95% CL: 95.4–99.4%). For FeLV, we report 100% sensitivity (95% CL: 97.7–100%) and 99.2% specificity (95% CL: 97.1–99.9%). And for heartworm, we report 90.2% sensitivity (95% CL: 76.9–97.3%) and 100% specificity (95% CL: 98.3–100%). Veterinarians may expect this performance relative to the reference methods they use for confirmatory serological testing.